{% text "preview_text" label="Preview Text", value="", no_wrapper=True %}
View in browser.
Feature
Sponsored Content
Design and Development Roads Converge at Biocompatibility
Adjusting design decisions later in the process to accommodate biocompatibility needs can be costly and time-consuming.
Design and Development Roads Converge at Biocompatibility

Biocompatibility is often treated as a milestone, a box to check on the path to regulatory approval. In reality, it is the cumulative outcome of hundreds of decisions made long before a device ever reaches a test lab. Every choice in materials, manufacturing processes, geometry, packaging, and sterilization shapes the biocompatibility profile of a medical device. When viewed through this lens, biocompatibility is not a test, but a design philosophy. And all roads, no matter where they begin, eventually lead to biocompatibility.

Material Selection: The First Fork in the Road

Material selection is the earliest and most influential determinant of biocompatibility. The chemical composition of a material—whether it’s a base polymer, metal alloy, ceramic, or composite—sets the foundation for the overall device biocompatibility. Ultimately, the material’s chemistry dictates the device’s biological profile. Poor material choices cannot be “tested out” later; they must be designed out from the start.

It is also important to remember that not all suppliers are the same. Where is the competition in that? In practice, each supplier has a proprietary mix for medical-grade polymers that can have significantly different chemical profiles. There is also a varying degree of…

Continue Reading